Business

Add as a preferred source on Google

Erasca Realigns Leadership to Support RAS Program Development

Chief Operating Officer Nicholas (Nik) Chetwyn, Ph.D., is scheduled to leave Nov. 2, with his duties shifting to other members of Erasca’s leadership team.

Updated 1 min read
Staff enter a biotechnology office and laboratory building in San Diego, California. (AI-generated image / EconoTimes)
Staff enter a biotechnology office and laboratory building in San Diego, California. (AI-generated image / EconoTimes)

Read the original article

In an SEC filing, Erasca said its realignment is meant to keep RAS-targeting programs moving through development and toward possible commercialization, with Chief Operating Officer Nicholas (Nik) Chetwyn, Ph.D., scheduled to leave Nov. 2.

Erasca said the redistribution of COO responsibilities among its leadership team would streamline the company’s reporting structure.

Related articles

View all